Founded in 1976, SOPHYSA was the pioneer in the development of adjustable neurosurgical valves to treat hydrocephalus. Introduced in 1984, the Sophy® valve was the first adjustable valve in the World allowing non-invasive adjustment of operating pressures, to match an individual patient's changing clinical needs.
Sophysa's core competency is the management of Cerebro-Spinal Fluid, allowing her to offer a platform of products for two major medical specialties, Neurosurgery and Neurotrauma.
In France and Benelux, Sophysa products are marketed by direct sales representatives. In the Rest of the World, Sophysa markets its products through an international network of exclusive distributors.
Sophysa will shortly share more information about the different trades availables in Sophysa.